comparemela.com

Latest Breaking News On - Ankur dhingra - Page 14 : comparemela.com

ProHance partners with Open Orbit to Expand into Australia and New Zealand

ProHance to replicate client success from other markets and deliver exceptional value to organizations in the Oceania region

ProHance announces entry in Australia & New Zealand by partnering with Open Orbit

SYDNEY, June 20, 2023 /PRNewswire/ ProHance, a leading omni-channel operations management solutions provider, announces its partnership with Open Orbit, a renowned process design and improvement company, as its Sales Channel Partner in Australia and New Zealand. ProHance offers a comprehensive omni-channel operations management and productivity platform that empowers enterprises to optimize their back-office, chat, and email servicing operations. With its real-time visibility capabilities, it enables organizations to gain insights into team engagement and effectively allocate resources. This visibility empowers enterprises to make data-driven decisions, distribute workload efficiently, and respond with agility to dynamic business demands. Ankur Dhingra, CEO, ProHance spoke about the partnership, stating, "ProHance has a strong track record of success in markets across Asia and North America. Our partnership creates unique value that enables data capture and analytics, as well as

ProHance expands to ANZ with Sydney s Open Orbit - Software

ProHance expands to ANZ with Sydney s Open Orbit - Software
crn.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from crn.com.au Daily Mail and Mail on Sunday newspapers.

BlueArk (BRK) Hits 24 Hour Trading Volume of $276,493 53

Shares of Summit Therapeutics Inc. (NASDAQ:SMMT – Get Rating) were down 6.1% during trading on Tuesday . The company traded as low as $1.55 and last traded at $1.55. Approximately 402,170 shares traded hands during mid-day trading, a decline of 83% from the average daily volume of 2,386,329 shares. The stock had previously closed at […]

Summit Therapeutics (NASDAQ:SMMT) Shares Gap Down to $1 83

Shares of Summit Therapeutics Inc. (NASDAQ:SMMT – Get Rating) gapped down before the market opened on Tuesday . The stock had previously closed at $1.83, but opened at $1.77. Summit Therapeutics shares last traded at $1.66, with a volume of 260,526 shares trading hands. Analyst Ratings Changes Separately, StockNews.com lowered Summit Therapeutics from a “hold” […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.